Results 21 to 30 of about 687,796 (199)
Progressive multifocal leukoencephalopathy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2020 doi：10.3969/j.issn.1672⁃6731.2020.03 ...
Xiao⁃ling YAN
doaj +2 more sources
Multifocal Leukoencephalopathy
Pediatric Neurology Briefs, 1994 A 15-year-old boy with Wiskott-Aldrich syndrome complicated by progressive multifocal leukoencephalopathy (PML) is reported from the University of Miami School of Medicine, FL, and the National Institute of Neurological Disorders and Stroke, Bethesda, MD.
J Gordon Millichap
doaj +2 more sources
International Journal of General Medicine, 2012 Katie Yoganathan1, David Brown2, Kathir Yoganathan31Cardiff Medical School, Cardiff, Wales, UK; 2Virus Reference Department, Microbiology Services, Health Protection Agency, London, UK; 3Singleton Hospital, Abertawe Bro Morgannwg University Health Board,
Yoganathan K, Brown D, Yoganathan K
doaj +1 more source
Progressive multifocal leukoencephalopathy [PDF]
Neurology, 2002 A 58-year-old woman admitted to the hospital had a 3-month history of progressive neurologic deterioration characterized by severe global aphasia and bilateral limb weakness, greater on the right. The patient had a 10-year history of systemic lupus erythematosus (SLE). Polyarthritis had been present for 6 weeks before the …
Henderson, R. D. +3 more
openaire +4 more sources
Progressive Multifocal Leukoencephalopathy [PDF]
F1000Research, 2015 Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease with significant morbidity and mortality and no effective, targeted therapies. It is most often observed in association with abnormalities of cell-mediated immunity, in particular human immunodeficiency virus (HIV) infection, but also occurs in association with ...
Adang, Laura, Berger, Joseph
openaire +3 more sources
Progressive multifocal leukoencephalopathy [PDF]
Current Neurology and Neuroscience Reports, 2000 Progressive multifocal leukoencephalopathy (PML) was a rare disease until the advent of the HIV/AIDS pandemic. Recent interest in the disorder has been spurred by its appearance in patients treated with the monoclonal antibodies natalizumab and rituximab.
openaire +5 more sources
AIDS Research and Therapy, 2020 The human neurotropic virus JC Polyomavirus, a member of the Polyomaviridae family, is the opportunistic infectious agent causing progressive multifocal leukoencephalopathy, typically in immunocompromised individuals.
Vijay Harypursat +3 more
doaj +1 more source
Cerebral lesions in hematological malignancies: a case report
Journal of Medical Case Reports, 2021 Background Progressive multifocal leukoencephalopathy is a rare central nervous system disease, resulting from reactivation of latent John Cunningham virus.
Nicoletta D’Ettore +3 more
doaj +1 more source
PARP-1 deregulation in multiple sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019 Background Poly (ADP-ribose) polymerase 1 (PARP-1) plays pivotal roles in immune and inflammatory responses. Accumulating evidence suggests PARP-1 as a promising target for immunomodulation in multiple sclerosis and natalizumab-associated progressive ...
Maria Meira +8 more
doaj +1 more source
International Journal of Infectious Diseases, 2023 This report presents the case of a 47-year-old male patient who worked as a mathematics teacher and experienced the sudden onset of disorientation, aphasia, and acalculia during an online class.
Yago Marcos Pessoa-Gonçalves +10 more
doaj +1 more source